Pay in 4 interest-free payments of $6.84 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
The most effective approach layers multiple interventions simultaneously
We interpret the clinical and mechanistic data obtained for different agents that enable weight loss and glucose control for the treatment of obesity and type 2 diabetes mellitus, respectively, by activating or blocking GIPR signalling, including the GIPRGLP1R co-agonist tirzepatide, as well as the GIPR antagonistGLP1R agonist AMG-133
Beyond the prescription: global observations on the social implications of GLP-1 receptor agonists for weight loss
This medication is 94% similar to the natural GLP-1 hormone and, just like the natural version, it binds to GLP-1 receptors in your pancreas and other organs
The standard adult dose is 125 mg after meals and at bedtime, up to 500 mg per day
US$ 29.09
US$ 24.03
US$ 26.66
US$ 26.09
